REQUEST A DEMO
Total
USD $0.00
Search more companies

Tri Swiss Implants Triswissimplants Cia.Ltda (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Tri Swiss Implants Triswissimplants Cia.Ltda Profile Updated: May 15, 2024
Buy our report for this company USD 19.99 Most recent financial data: 2020 Available in: English & Spanish Download a sample report

Tri Swiss Implants Triswissimplants Cia.Ltda is based in Ecuador, with the head office in Quito. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The enterprise was incorporated on August 15, 2019. The company’s latest financial report indicates a net sales revenue increase of 461.68% in 2020. Its total assets grew by 255.81% over the same period. The net profit margin of Tri Swiss Implants Triswissimplants Cia.Ltda increased by 18.49% in 2020.

Headquarters
Rumipamba E2-214
Quito; Pichincha;

Contact Details: Purchase the Tri Swiss Implants Triswissimplants Cia.Ltda report to view the information.

Basic Information
Outstanding Shares:
Purchase the Tri Swiss Implants Triswissimplants Cia.Ltda report to view the information.
Registered Capital:
Purchase the Tri Swiss Implants Triswissimplants Cia.Ltda report to view the information.
Incorporation Date:
August 15, 2019
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
33.5%
Purchase this report to view the information.
33.25%
Purchase this report to view the information.
33.25%
Company Performance
Financial values in the chart are available after Tri Swiss Implants Triswissimplants Cia.Ltda report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
461.68%
Total operating revenue
461.3%
Operating profit (EBIT)
778.67%
EBITDA
777.82%
Net Profit (Loss) for the Period
759.08%
Total assets
255.81%
Total equity
743.84%
Operating Profit Margin (ROS)
19.76%
Net Profit Margin
18.49%
Return on Equity (ROE)
1.56%
Quick Ratio
1.21%
Cash Ratio
-0.38%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?